RWJ-56110 dihydrochloride
≥99%
- Product Code: 109499
CAS:
2387505-58-8
Molecular Weight: | 863.65 g./mol | Molecular Formula: | C₄₁H₄₅Cl₄F₂N₇O₃ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
RWJ-56110 dihydrochloride is primarily utilized in research settings for its role as a selective inhibitor of the enzyme dipeptidyl peptidase IV (DPP-4). This enzyme plays a significant role in glucose metabolism, making the compound of interest in studies related to type 2 diabetes. By inhibiting DPP-4, it helps enhance the activity of incretin hormones, which are crucial for regulating blood sugar levels. Researchers use this compound to explore potential therapeutic strategies for managing diabetes and understanding the underlying mechanisms of glucose homeostasis. Additionally, it serves as a valuable tool in pharmacological studies aimed at developing new treatments for metabolic disorders. Its application extends to preclinical investigations, where it aids in evaluating the efficacy and safety of DPP-4 inhibitors in animal models.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.005 | 10-20 days | ฿52,200.00 |
+
-
|
0.010 | 10-20 days | ฿88,200.00 |
+
-
|
0.025 | 10-20 days | ฿171,000.00 |
+
-
|
RWJ-56110 dihydrochloride
RWJ-56110 dihydrochloride is primarily utilized in research settings for its role as a selective inhibitor of the enzyme dipeptidyl peptidase IV (DPP-4). This enzyme plays a significant role in glucose metabolism, making the compound of interest in studies related to type 2 diabetes. By inhibiting DPP-4, it helps enhance the activity of incretin hormones, which are crucial for regulating blood sugar levels. Researchers use this compound to explore potential therapeutic strategies for managing diabetes and understanding the underlying mechanisms of glucose homeostasis. Additionally, it serves as a valuable tool in pharmacological studies aimed at developing new treatments for metabolic disorders. Its application extends to preclinical investigations, where it aids in evaluating the efficacy and safety of DPP-4 inhibitors in animal models.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :